AbbVie, Capstan Therapeutics and other defendants were hit with a trade secret lawsuit on Sept. 23 in California Southern District Court. The suit, filed by Wilson Sonsini Goodrich & Rosati on behalf ...
Sept 23 (Reuters) - Biotech company Arcturus Therapeutics (ARCT.O), opens new tab sued AbbVie (ABBV.N), opens new tab in California federal court on Tuesday for allegedly stealing trade secrets ...
Arcturus Therapeutics is transitioning from COVID-era revenues to milestone-driven growth, led by its mRNA platform and strategic partnerships. KOSTAIVE, ARCT's self-amplifying mRNA COVID-19 vaccine, ...
Arcturus Therapeutics (ARCT) shares soared 8.7% in the last trading session to close at $19.62. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Arcturus Therapeutics ( (ARCT)) has ...
SSC GD admit card 2025: The Central Reserve Police Force has released the SSC GD Constable PET/PST admit cards 2025 at rect.crpf.gov.in. Shortlisted candidates from the CBT stage can now download ...
Arcturus Therapeutics Holdings Inc’s stock price closed at $11.40. It is down -2.06% in the last 3 months and down -42.04% in the last 12 months. Arcturus Therapeutics Holdings Inc saw 0 positive EPS ...
A review and overview of the Arcturus Backwoods wool blanket featuring a classic red buffalo plaid design. The video highlights its warmth, durability, and suitability for outdoor and camping use.
San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work in an effort to prioritize spending and extend its cash runway. In a brief ...
During the last three months, 7 analysts shared their evaluations of Arcturus Therapeutics ARCT, revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ratings ...
Arcturus Therapeutics believes it’s “highly unlikely” it will lose the promised government funding for its bird flu mRNA vaccine trial, despite reports swirling that Moderna’s own financial support ...
Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public skepticism (35% comfortable with technology) and challenges translating success ...